期刊文献+

流感病毒感染小鼠肺巨噬细胞Dll1和MHC-Ⅰ表达研究 被引量:7

Notch-Dll1 and MHC-Ⅰexpression in pulmonary alveolar macrophages of mice infected with influenza virus
下载PDF
导出
摘要 目的探讨小鼠肺巨噬细胞Dll1及MHC-Ⅰ与细胞毒性T淋巴细胞(CTL)为主的细胞免疫应答的关系,为制备有效的新型抗流感病毒疫苗提供理论依据。方法将小鼠随机分为3组,异型免疫组(用rL-H5株重组二联活疫苗免疫)、同型免疫组(用A/H1N1流感病毒免疫)和未免疫感染组(用PBS代替疫苗),不同疫苗免疫小鼠后均感染A/H1N1型流感病毒,比较3组小鼠肺巨噬细胞Notch-Dll1及MHC-Ⅰ表达情况,并研究干扰素(IFN)-γ、T细胞水平变化。结果异型免疫组感染4 d和7 d后,肺巨噬细胞Notch-Dll1[分别为(0.01460±0.00125)和(0.01750±0.00196)]及MHC-ⅠmRNA表达水平[分别为(0.03050±0.0029)和(0.0495±0.0024)]显著高于感染前[分别为(0.00045±0.00004)和(0.0120±0.0018)],未免疫感染组感染4 d和7 d后Notch-Dll1[分别为(0.01010±0.00107)和(0.01320±0.00143)]和MHC-ⅠmRNA表达水平[分别为(0.0219±0.0024)和(0.0248±0.0022)]均高于感染前[分别为(0.00032±0.00007)和(0.0090±0.0013)];异型免疫组感染4 d和7 d,后Notch-Dll1和MHC-ⅠmRNA表达水平均高于同型免疫组[感染4 d和7 d后,Notch-Dll1分别为(0.00089±0.00018)和(0.00143±0.00096),MHC-ⅠmRNA分别为(0.0038±0.0008)和(0.0008±0.0002)及未免疫感染组,差异均具有统计学意义(均P<0.05)。感染后第7天,异型免疫组IFN-γ、CD8+T细胞的百分比含量为(3.31±0.34)%,高于同型免疫组和未免疫感染组[分别为(0.38±0.06)%和(1.58±0.27)%];感染后第5天,异型免疫组流感病毒量为[(6.26×105)±(3.7×105)]copies/μL,低于未免疫感染组[(6.85×107)±(2×107)]copies/μL,而高于同型免疫组(400±250)copies/μL(均P<0.05)。结论小鼠肺巨噬细胞Dll1及MHC-Ⅰ的表达可能在以CTL为主流感病毒异型交叉保护免疫应答反应中起重要作用。 Objective To study the relationship between Notch ligand Delta-like 1 (Dll1 ),MHC class I molecule (MHC-Ⅰ)in mice pulmonary alveolar macrophages (PAM)and cellular immunity response based on cytotoxic T-lympho-cytes(CTLs),and provide theoretical basis for the preparation of vaccine against influenza virus.Methods Mice were ran-domly divided into 3 groups:heterosubtypic immune group(immunized with recombinant virus vaccine rL-H5 ),homosub-typic immune group (immunized with A/H1N1 influenza virus vaccine),and viral infection group(immunized with PBS). Mice immunized with different vaccines were all infected with A/H1N1 influenza virus.mRNA expression of Notch-Dll1 and MHC-Ⅰamong 3 groups were compared,levels of IFN-γand T cells in 3 groups were studied.Results At day 4,7 of post-infection,in heterosubtypic immune group,mRNA expression of Notch-Dll1 ( [0.01460 ± 0.00125 ]),[0.01750±0.00196])and MHC-Ⅰ ([0.03050±0.0029],[0.0495±0.0024])were both higher than those before infection ([0.00045±0.00004],[0.0120±0.0018]),in viral infection group,mRNA expression of Notch-Dll1 ([0.01010±0.00107],[0.01320 ±0.00143])and MHC-Ⅰ ([0.0219 ±0.0024],[0.0248 ±0.0022])were both higher than those before infection([0.00032±0.00007],[0.0090±0.0013]);At day 4,7 of post-infection ,mR-NA expression of Notch-Dll1 and MHC-Ⅰ in heterosubtypic immune group were both higher than those in homo-subtypic immune group (Notch-Dll1 [0.00089 ±0.00018],[0.00143 ±0.00096];MHC-Ⅰ [0.0038 ±0.0008], [0.0008±0.0002 ])and viral infection group,the difference was statistically significant(all P 〈0.05).At day 7 of post-infection,the percentage of IFN-γand CD8+T cells in heterosubtypic immune group was(3.31 ±0.34)% ,which was significantly higher than homosubtypic immune group ([0.38±0.06]%)and viral infection group ([1.58±0.27]%);At day 5 of post-infection ,viral load of heterosubtypic immune group ([6.26×105 ±3.7×105 ]copies/μL)was lower than that of viral infection group ([6.85×107 ±2×107 ]copies/μL),but higher than that of homosubtypic immune group([400 ±250 ]copies/μL )(all P 〈0.05).Conclusion Notch-Dll1 and MHC-Ⅰ in mice PAM may play active roles by pro-moting CTL differentiation during heterosubtypic immune against influenza virus.
出处 《中国感染控制杂志》 CAS 2014年第8期449-453,共5页 Chinese Journal of Infection Control
基金 高等学校博士学科点专项科研基金(20102104110018)
关键词 流感病毒 巨噬细胞 异型 Notch-Dll1 MHC-Ⅰ 细胞毒性T淋巴细胞 influenza virus macrophage heterosubtypic cytotoxic T lymphocyte
  • 相关文献

参考文献2

二级参考文献31

  • 1姚春艳,姜丽娜,郭术俊,马华.腹腔注射IL-2对小鼠单核吞噬细胞吞噬功能的影响[J].山西医科大学学报,2007,38(3):202-203. 被引量:4
  • 2Hsieh YC, Wu TZ, Liu DP, et al. Influenza pandemics: past, present and future [J]. J Formos Med Assoc,2006,105 ( 1 ) : 1-6.
  • 3Flahauh A,Vergu E, Boene PY. Potential for a global dynamic of influenza A (H1N1) [J]. BMC Infect Dis,2009,9 ( 1 ) :129.
  • 4Sorianov,Gonzalez-Lahoz J. The challenge of the new H1N1 influenza A [J]. Med Clin (Barc) ,2009,133 ( 18 ) :708-709.
  • 5De Jong MD, Tran TR, Tmong HK, et al. Oseltamivir resistance during treatment of influenza A (H1N1) infection [J]. N EllgI J Med, 2005,353 (25) :2667-2672.
  • 6Tamura SI, Tanimoto T, Kurata T. Mechanisms of broad crossprotection provided by influenza virus infection and their application to vaccines[ J]. Infect Dis,2005,58 : 195-207.
  • 7Boon AC, de Mutsert G, van Baarle D, et al. Recognition of hemo-and heterosubtypie variants of influenza A viruses by human CD8^+ T lymphoeytes[ J]. Immunol,2004,172 (4) :2453- 2460.
  • 8Nguyen HH, Ginkel FW, Vu HL, et al. Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8^+ cytotoxic T lymphocytes [J]. J Infect Dis, 2001,183 ( 3 ) :368- 376.
  • 9Droebner K, Haasbach E, Fuchs C, et al. Antibodies and CD4^+-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic HSN2 strain[J]. Vaccine ,2008,26 (52) :6965-6974.
  • 10Ichinohe T, Ainai A, Nakamura T, et al. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia [ J ]. Med Virol,2010,82( 1 ) :128-137.

共引文献36

同被引文献65

  • 1Roberto Bringiotti,Enzo Ierardi,Rosa Lovero,Giuseppe Losurdo,Alfredo Di Leo,Mariabeatrice Principi.Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?[J].World Journal of Gastrointestinal Pathophysiology,2014,5(4):550-559. 被引量:20
  • 2罗凡,侯炜,杨占秋,郝建新,锡谷达夫,森修一.草血竭抗流感病毒的研究[J].武汉大学学报(医学版),2006,27(1):72-74. 被引量:6
  • 3李国勤,卢立志,王得前,沈军达,陶争荣,赵爱珍,原爱平.鸡MHC基因多态性与抗病性状的相关性研究进展[J].农业生物技术学报,2006,14(1):122-127. 被引量:4
  • 4王海,黄茜华,彭春梅,唐妮,李川江,朱冰,陈翊,周荣.实时荧光PCR方法在A型流感病毒检测中的应用[J].热带医学杂志,2006,6(10):1077-1080. 被引量:14
  • 5Larue L, Bellacosa A. Epithelial-mesenchymal transition in devel opmen* and cancer role of phosphatidtlinositol 3kinase/AKT pathways[J]. Oncogene, 2005, 24(50): 7443 54.
  • 6Rebay I, Fehon RG, Tsakonas A. Specific truncations of Dro sophila Notch define dominant activated and dominant negative forms of the receptor[J]. Cell, 1993, 74(2): 319--29.
  • 7Shawber CJ, Kitajewski J. Notch function in the vasculatu: in sights form zehrafish mouse and man[J]. Bioessays, 2001, 26 (3): 225--34.
  • 8Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system[J]. Immunity, 2010, 32(1): 14-27.
  • 9Palaga T, Miele I., Golde TE, et al. TCR mediated Notch signa ling regulates proliferation and IFN-gamma production in periph eralT cells[J]. Immunol, 2003, 171(6): 3019 24.
  • 10Anastasi E, Campese AF, Bellavia, et al. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diahetes[J]. Immunol, 2003, 171(9): 4504--11.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部